Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus—Safety Lead-in Results of a Phase 2 Trial
Vitaly Margulis, Yuval Freifeld, Laurentiu M. Pop, Subrata Manna, Payal Kapur, Iván Pedrosa, Alana Christie, Osama Mohamad, Samantha Mannala, Nirmish Singla, Michael A. Wait, Aditya Bagrodia, Solomon L. Woldu, Jeffrey Gahan, James Brugarolas, Robert Timmerman, Raquibul Hannan
Topics & Concepts
MedicineRenal cell carcinomaInferior vena cavaSABR volatility modelRadiologyThrombusCarcinomaCardiologyInternal medicineUrologyStochastic volatilityVolatility (finance)EconomicsFinancial economicsRenal cell carcinoma treatmentCardiac tumors and thrombiBladder and Urothelial Cancer Treatments